Skip to main navigation

Medical Device Coatings
Interventional Products
In Vitro Diagnostics
Investors
Our Company
- About Surmodics
- Ireland Facility
Careers
Contact Us

News Releases

News Releases

2024
2023
2022
Archive
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004

November 16, 2023

Surmodics Announces 24-Month Data from the SWING Trial Presented at VEITHsymposium

November 16, 2023

Surmodics Announces TRANSCEND Trial 36-Month Data Presented at 50th Annual VEITH Symposium

November 14, 2023

Surmodics to Participate in the Piper Sandler Healthcare Conference on November 28

November 8, 2023

Surmodics Reports Fourth Quarter and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Financial Guidance

November 7, 2023

Surmodics Announces TRANSCEND Trial 36-Month Data to be Presented at 50th Annual VEITH Symposium

November 7, 2023

Surmodics Announces SWING Trial 24-Month Data to be Presented at VEITH Symposium on November 15

October 31, 2023

Surmodics Announces Launch of Preside™ Medical Device Coating Technology, Providing Industry-Leading Lubricity and Durability to a Broader Range of Complex Device Applications

October 10, 2023

Surmodics to Report Fourth Quarter and Fiscal 2023 Financial Results on November 8

August 9, 2023

Surmodics to Participate in Upcoming Investor Conferences in August

August 2, 2023

Surmodics Reports Third Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance

July 12, 2023

Surmodics to Report Third Quarter of Fiscal 2023 Financial Results on August 2

June 20, 2023

Surmodics Receives FDA Approval for the SurVeil™ Drug-Coated Balloon

June 14, 2023

Surmodics Receives FDA 510(k) Clearance for Pounce™ LP Thrombectomy System

May 25, 2023

Surmodics to Participate in the Jefferies Healthcare Conference on June 8

April 26, 2023

Surmodics Reports Second Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance

April 20, 2023

Surmodics Announces First Patient Enrolled in PROWL Registry Study Using the Pounce™ Thrombectomy System

April 19, 2023

Surmodics to Report Second Quarter of Fiscal 2023 Financial Results on April 26

April 19, 2023

Surmodics Announces Successful First Patient Use of Sublime™ Radial Access Microcatheter Designed for the Periphery

April 11, 2023

Surmodics to Participate in the 22nd Annual Needham Virtual Healthcare Conference on April 20

March 28, 2023

Surmodics Provides Regulatory Update on its Strategy to Submit an Amended Premarket Approval Application for the SurVeil™ Drug-Coated Balloon

March 8, 2023

Surmodics to Participate in Upcoming Investor Conferences in March

February 6, 2023

Surmodics Reports First Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance

January 31, 2023

Surmodics to Host Virtual Annual Meeting of Shareholders

January 26, 2023

Surmodics to Report First Quarter of Fiscal 2023 Financial Results on February 6

January 19, 2023

Differentiated Capabilities of Surmodics’ Crystalline Drug Release Platform for Sirolimus-Coated Balloons Presented at ISET Conference

January 19, 2023

Surmodics Provides Regulatory Update Related to its FDA Premarket Approval Application for the SurVeil™ Drug-Coated Balloon

January 16, 2023

Surmodics Announces SWING Trial 12-Month Data to be Presented at ISET Conference on January 18

Shareholder Tools

Corporate

9924 West 74th Street
Eden Prairie, MN 55344
USA
Toll Free: 1-866-787-6639
Phone: 952-500-7000
Fax: 952-500-7001

Golden Triangle

7905 Golden Triangle Drive
Suite 190
Eden Prairie, MN 55344
USA
Toll Free: 1-888-626-8501
Phone: 952-500-7400
Fax: 952-500-7001

Ireland

IDA Business Park
Ballinasloe, Co. Galway
Ireland
Phone +353 90 9646300
Fax +353 90 9646309

Products

Interventional Products
Performance Coatings
Drug-Coated Balloons
In Vitro Diagnostics

Our Company

About Surmodics
Contact Us
Investors
Careers

Documents

eIFUs
Privacy Policy
Term of Use

© 2024 Surmodics, Inc. All Rights Reserved.